financetom
Business
financetom
/
Business
/
Rein Therapeutics Shares Lower After Brookline Capital Downgrade
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rein Therapeutics Shares Lower After Brookline Capital Downgrade
Aug 20, 2025 3:55 AM

03:03 PM EDT, 08/19/2025 (MT Newswires) -- Rein Therapeutics ( RNTX ) shares fell 6.2% in recent Tuesday trading after Brookline Capital downgraded the stock to hold from buy.

Trading volume stood at over 54,901 shares, versus the daily average of 42,806.

Price: 1.06, Change: -0.07, Percent Change: -6.19

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved